James River to Hold Its Fourth Quarter Earnings Conference Call on Tuesday, March 3, 2026 CHAPEL HILL, N.C., Feb. 04, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) will release fourth quarter earnings after the market closes on Monday, March 2, 2026. It will also host an earnings conference call on Tuesday, March 3, 2026 beginning at 8:30 a.m. (Eastern Time). The conference call may be accessed by dialing (800) 715-9871, conference ID 6910670, or via the investor website at . A replay will also be available in the same location....
American Assets Trust, Inc. Reports Fourth Quarter and Year End 2025 Financial Results SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE: AAT) (the “company”) today reported financial results for its fourth quarter and year ended December 31, 2025. Fourth Quarter Highlights Net income available to common stockholders of $3.1 million and $55.6 million for the three months and year ended December 31, 2025, respectively, or $0.05 and $0.92 per diluted share, respectively.FFO of $0.47 and $2.00 per diluted share for the three months and year ended December 3...
American Assets Trust, Inc. Releases Tax Status of 2025 Distributions SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE: AAT) (the “Company”) announced today the tax treatment of its 2025 dividend distributions as follows: Security Descriptions: Common StockCUSIP: 024013104Ticker Symbol: AAT Record DatePayable DateTotal Distribution Per ShareAllocable to 2025Taxable Ordinary DividendLT Capital GainUnrecaptured Sec. 1250 GainSection 199A DividendsReturn of Capital03/06/2503/20/25$0.340$0.340$0.140480$0.059651$0.042897$0.140480$0.13986906/05/2506/19/25$0.340$0....
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results Company to present at the 44th Annual JP Morgan Healthcare Conference FREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the fourth quarter and full year ended December 31, 2025. Cytek expects its total revenue for the full year 2025 to be approximately $201 million. Expected revenue for the fourth quarter of 2025 of approximately $62 million represents grow...
American Assets Trust, Inc. Announces Fourth Quarter and Year-End 2025 Earnings Release Date and Conference Call Information SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its fourth quarter and year-end 2025 earnings in a press release to be issued after the market closes on Tuesday, February 3, 2026. Senior management will hold a conference call for its fourth quarter and year-end 2025 earnings on Wednesday, February 4, 2026 at 8:00 a.m. Pacific Time (“PT”). To access the conference call, please dial 1 (833) 816-1162 a...
Occidental to Announce Fourth Quarter Results Wednesday, February 18, 2026; Hold Conference Call Thursday, February 19, 2026 HOUSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- (NYSE: OXY) will announce its fourth quarter 2025 financial results after close of market on Wednesday, February 18, 2026, and will hold a conference call to discuss the results on Thursday, February 19, 2026, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at . Participants may pre-register for the conference call ...
Occidental Completes Sale of OxyChem HOUSTON, Jan. 02, 2026 (GLOBE NEWSWIRE) -- (NYSE: OXY) announced today it has completed the sale of its chemical business, OxyChem, to Berkshire Hathaway (NYSE: BRK.A, BRK.B) for $9.7 billion in cash, subject to customary purchase price adjustments. “This transaction accelerates our strategy to strengthen Occidental’s balance sheet and focus on our deep and diverse oil and gas portfolio which we have transformed over the last decade. We expect to operate our high-return oil and gas assets to deliver long-term value while driving innovation across our...
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026 FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader (Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global data firm Statista, the inaugural ranking recognizes the top-performing publicly listed companies in the United States that have demonstrated exceptional growth, financial stability, and stock performance over the past five years. According to TIME and Statista, thousands of businesses are founded i...
Occidental Announces Third Quarter 2025 Results HOUSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- (NYSE: OXY) today announced its third quarter 2025 financial results. The earnings release and accompanying financial schedules can be accessed via the section of the company’s website at . The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Tuesday, November 11, 2025, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (internati...
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CTKB) announced today that its has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards. The annual program, conducted by leading independent market intelligence organization , recognizes innovative life sciences and biotechnology companies, products, and services worldwide. This year’s competition drew thousands of nominations from more than 15 countries. The award highlights Cytek’s commi...
Cytek Biosciences to Participate in Upcoming Investor Conferences FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Global Healthcare Conference in Palm Beach, FLParticipating in investor 1x1 meetings on Tuesday, November 11, 2025 Stephens NASH25 Investment Conference in Nashville, TNFireside chat on November 19, 2025, at 9:00 a.m. Pacific Time /12:00 p.m. Eastern Time Piper Sandler 37th Annual Healthcare Confer...
Cytek Biosciences Reports Third Quarter 2025 Financial Results FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Total revenue for the third quarter of 2025 was $52.3 million, representing a 2% increase compared to the third quarter of 2024Expanded to a total installed base of 3,456 Cytek instruments, adding 161 units in the third quarter of 2025Double-digit total revenue g...
Occidental Announces Dividend HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- (NYSE: OXY) announced today that its Board of Directors declared a regular quarterly dividend of $0.24 per share on common stock, payable on January 15, 2026, to stockholders of record as of the close of business on December 10, 2025. About Occidental is an international energy company with assets primarily in the United States, the Middle East and North Africa. We are one of the largest in the U.S., including a leading producer in the Permian and DJ basins, and offshore Gulf of America. Our provides flow assur...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.